Diaceutics wins Covid-19 testing data licensing contract | 1 April 2021
1 April 2021 | 07:55am StockMarketWire.com - Healthcare diagnostic company Diaceutics said it had won a data licensing contract with a pharmaceutical company to provide COVID-19 testing data insights in the US. This contract win highlights that the group is in a position to address the imminent opportunity presented by the COVID-19 treatment market using its DXRX data solution capabilities, the company said. The financial details of the contract werent disclosed and the company said the contrac...
Source: stockmarketwire.com